Pictet Asset Management Holding SA »

Celldex Therapeutics shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-09-30 $39M 1.1M 33.99
2024-03-31 $63M 1.5M 41.97

More positions owned by Pictet Asset Management Holding SA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Thermo Fisher Scientific (TMO)
Amazon (AMZN)
Republic Services (RSG)
Meta Platforms Cl A (META)
salesforce (CRM)
Waste Connections (WCN)
Equinix (EQIX)
Ecolab (ECL)
Ubs Group SHS (UBS)
Kla Corp Com New (KLAC)
Broadcom (AVGO)

View all positions for Pictet Asset Management Holding SA

Top funds holding Celldex Therapeutics

BlackRock
BlackRock
Vanguard Group
Kynam Capital Management
Eventide Asset Management
Bellevue Group
T. Rowe Price Associates
State Street Corporation
Woodline Partners
T. Rowe Price Investment Management
Point72 Asset Management
Commodore Capital
Geode Capital Management
Rock Springs Capital Management
Jennison Associates

View all funds holding Celldex Therapeutics